Charles River Laboratories International (CRL) Current Assets (2009 - 2025)

Charles River Laboratories International (CRL) has reported Current Assets for 17 consecutive years, with $1.4 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Current Assets rose 3.13% year-over-year to $1.4 billion; the TTM figure through Dec 2025 stood at $1.4 billion (up 3.13% YoY), while the FY2025 annual figure was $1.4 billion, up 3.13% from the prior year.
• Current Assets came in at $1.4 billion for Q4 2025 at Charles River Laboratories International, down from $1.5 billion in the prior quarter.
• The five-year high for Current Assets was $1.7 billion in Q1 2024, with the low at $1.3 billion in Q2 2021.
• Average Current Assets over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2023.
• Across the five-year window, Current Assets climbed 17.79% in 2021 and dropped 12.78% in 2024, its largest moves.
• Year by year, Current Assets stood at $1.3 billion in 2021, then climbed by 12.95% to $1.4 billion in 2022, then increased by 11.79% to $1.6 billion in 2023, then dropped by 12.78% to $1.4 billion in 2024, then rose by 3.13% to $1.4 billion in 2025.
• According to Business Quant data, Current Assets over the past three periods registered $1.4 billion, $1.5 billion, and $1.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.